Clinical Trial Update: Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether postoperative adjuvant cisplatin-based chemoradiotherapy improves outcomes compared with adjuvant radiotherapy alone f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Squamous Cell Cancer of Head and Neck (SCCHN) | Phase 3 | Status: RECRUITING